Monthly Archives: February 2018

Feb 2018

Press Release: Cyntegrity Rolls out SaaS Application to Help Pharma Organisations Bring Regulatory Guidance into Practice

By |2018-02-27T13:18:32+00:00February 27, 2018|News|Comments Off on Press Release: Cyntegrity Rolls out SaaS Application to Help Pharma Organisations Bring Regulatory Guidance into Practice

Frankfurt – Cyntegrity, a German provider of proprietary Risk-based Monitoring (RBM) cloud services for the Life Sciences industry, today announced the rollout of “@RACT-Pro” – simple and affordable risk assessment and mitigation tool. There is even a free version. This online SaaS (software as [...]

Feb 2018

What is the Cost of Poor Quality in Pharma?

By |2018-04-05T15:16:39+01:00February 20, 2018|Blog, Library|Comments Off on What is the Cost of Poor Quality in Pharma?

Quality is a business decision. Everyone instinctively knows that poor quality doesn't come cheap, however until now no attempt was made to calculate the real difference between good and poor quality in clinical trials. Most of the issues that impact cost and expenses are lurking just below the tip of the iceberg.

Feb 2018

Webinar: Best Practices in Defining KRIs for Clinical Trials

By |2018-02-13T17:33:55+00:00February 13, 2018|Webinar|Comments Off on Webinar: Best Practices in Defining KRIs for Clinical Trials

Are your role connected with the controlling the quality, performance or risks of clinical trials? We are delighted to invite you along to this exclusive live webinar and Q&A session on February 23rd, 2018.

Feb 2018

Adaptive Monitoring: The First Implementation Steps in Real-Life

By |2018-03-07T12:56:48+00:00February 13, 2018|Blog, Case Study|1 Comment

It is widely broadcasted that pharma companies will have to accelerate adoption of adaptive clinical trial designs to reduce study timelines and costs while increasing success rates. Risk-based Monitoring “Real RBM” integrates the Adaptive Monitoring (AM) process, which addresses all aspects of Quality Risk Management.

Feb 2018

Dr Nimita Limaye: “KRI Wiki is a Path Breaking Initiative”

By |2018-02-12T11:14:09+00:00February 7, 2018|News, Weekly RBM Feature|Comments Off on Dr Nimita Limaye: “KRI Wiki is a Path Breaking Initiative”

We are pleased to welcome Dr Nimita Limaye, Project Lead KRI Wiki, to the Cyntegrity team! Key Risk Indicators (KRIs) play a fundamental role in managing risk, you could say they are the “traffic lights” of clinical monitoring. When appropriately selected and calibrated KRIs [...]

Upcoming Events

  1. SCDM 2018 ANNUAL CONFERENCE – Seattle

    September 23 - September 26

Register Today!

Get Free Test Access